Leishmaniasis is a disease caused by parasites that belong to the genus Leishmania and is transmitted by the bite of certain species of sandfly, including flies in the genus Lutzomyia in the New World and Phlebotomus in the Old World. The disease was named in 1901 for the Scottish pathologist William Boog Leishman.This disease is also known as Leichmaniosis, Leishmaniose, leishmaniose, and formerly, Orient Boils, kala azar, black fever, sandfly disease, Dum-Dum fever or espundia.
Most forms of the disease are transmittable only from animals (zoonosis), but some can be spread between humans. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with three species (L. donovani, L. infantum, and L. chagasi); the L. mexicana complex with 3 main species (L. mexicana, L. amazonensis, and L. venezuelensis); L. tropica; L. major; L. aethiopica; and the subgenus Viannia with four main species (L. (V.) braziliensis, L. (V.) guyanensis, L. (V.) panamensis, and L. (V.) peruviana). The different species are morphologically indistinguishable, but they can be differentiated by isoenzyme analysis, DNA sequence analysis, or monoclonal antibodies.
Geography and epidemiology
Leishmaniasis can be transmitted in many tropical and sub-tropical countries, and is found in parts of about 88 countries. Approximately 350 million people live in these areas. The settings in which leishmaniasis is found range from rainforests in Central and South America to deserts in West Asia. More than 90 percent of the world's cases of visceral leishmaniasis are in India, Bangladesh, Nepal, Sudan, and Brazil.
More on
[ Leishmaniasis ]
Vector Borne
Zoonoses
Filaria Journal - Latest ArticlesContribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico.Mario Rodriguez-PerezAldo Segura-CabreraCristian Lizarazo-OrtegaMaria-Gloria BasanezJohn Davies Tue, 18 Dec 2007 00:00:00 -0000
Background:
Since 1991, in Mexico, ivermectin has been administered twice a year to all residents in the onchocerciasis endemic foci which are mainly located in the coffee growing areas. However, the presence of a potentially infected itinerant seasonal labour force which is not treated regularly could jeopardise the attainment of the 85% coverage which is the present target for elimination of the disease.
Methods:
The prevalence and intensity of Onchocerca volvulus microfilariae (mf), as well as their transmission from humans to vectors, were assessed during the coffee planting-clearing and harvesting seasons of 1997–1998, and 1998–1999 in two localities (I and II) of Southern Chiapas, Mexico, which regularly receive an influx of untreated migrant coffee labourers.
Results:
Localities I and II had, respectively, an average of 391 (± 32) and 358 (± 14) resident inhabitants, and 70 (± 52) and 498 (± 289) temporary labourers. The ratio of migrants to residents ranged from 0.1:1 in locality I to 2.4:1 in locality II. The proportion of infected Simulium ochraceum s.l. parous flies was significantly lower in locality I than in locality II, and significantly higher during the stay of the migrants than before their arrival or after their departure. Parity and infection were higher in May-July than in November-February (in contrast with the latter being typically considered as the peak onchocerciasis transmission season by S. ochraceum s.l.).
Conclusion:
The presence of significant numbers of untreated and potentially infected migrants may contribute to ongoing transmission, and their incorporation into ivermectin programmes should be beneficial for the attainment of the elimination goals of the regional initiative. However, the possibility that the results also reflect transmission patterns for the area cannot be excluded and these should be analyzed further.
Epidemiology and psycho-social aspects Of onchocercal skin
diseases in northeastern Nigeria
Ikem OkoyeCelestine Onwuliri Mon, 03 Dec 2007 00:00:00 -0000
Background:
Observations were made on the prevalence of onchocerciasis and Onchocercal Skin Diseases (OSD); frequency of occurrence and anatomical distribution of OSD in the Hawal River Valley, an established onchocerciasis endemic focus in north-eastern Nigeria.
Methods:
Symptoms of OSD were diagnosed in 5 844 subjects using Rapid Assessment Method (RAM) while 1 479 of the subjects chosen from alternate households had their skin biopsies examined for active microfilariae of Onchocerca volvulus. Also, Focal Group Discussions (FGD) were conducted at the Health District levels.
Results:
O. volvulus was recorded in (19.0%) and OSD in (43.8%) of the subjects. The Mantel-Haenszel test for linear association showed a close agreement between onchocerciasis prevalence and the rate of OSD (χ2 = 3.93; p < 0.05). The various forms of OSD occurred in the order: CPOD (17.7%), APOD (9.9%), DPM (9.0%), LOD (7.0%) and ATR (3.1%). The overall frequency of occurrence of various symptoms of OSD on different anatomical locations showed the locations in descending order of occurrence as lower limbs (24.6%), upper limbs (21.3%), buttocks (19.9%), shoulder & neck (19.1%), abdomen and trunk (11.3%), backside (10.6), and 'other' sites (7.5%). The Focal Group Discussion (FGD) revealed the most worrisome consequences of OSD as social isolation of victims (31.3%), shame and low self esteem (22.7%) and high cost of medication (15.6%).
Conclusion:
It is recommended that Onchocerciasis control programmes in the Hawal River Valley and any other focus with high incidence of OSD should incorporate an aspect that would address the anxiety and depression caused by various OSD lesions since they carry lots of psycho-social implications. This would increase acceptance and compliance of the target population. The classification criteria of onchocerciasis endemicity should be based on either or both of the O. volvulus and onchocercal skin disease burden of any community and no longer on O. volvulus parasitic infection rate alone.
Contributions of different mosquito species to the transmission of lymphatic filariasis in central Nigeria: Implications for monitoring infection by PCR in mosquito poolsAudrey LenhartAbel EigegeAlphonsus KalD PamEmmanuel MiriGeorge GerlongJ OneykaY SamboJ DanboyiB IbrahimErica DahlD KumbakA DakulM JinaduJohn UmaruFrank RichardsTovi Lehmann Thu, 29 Nov 2007 00:00:00 -0000
Background:
Members of the Anopheles gambiae complex are important vectors of lymphatic filariasis (LF) in sub-Saharan Africa, but little is known about the relative contributions of all mosquitoes to lymphatic filariasis transmission in this area.
Methods:
Over a 28 month period, mosquitoes were collected from 13 villages in Plateau and Nasarawa states in central Nigeria and dissected to determine W. bancrofti infection status. Wings and legs from a subset of the mosquitoes visually identified as A. gambiae s.l. were identified by PCR as either A. gambiae s.s. or A. arabiensis.
Results:
A. gambiae s.s peaked in abundance during the rainy season while A. arabiensis predominated during drier parts of the year. Both species were found equally likely to be infected with the developing stages (L1-L3) of W. bancrofti (9.2% and 11.1%, respectively). Fewer A. funestus (1.1%, p < 0.001) were infected than A. gambiae s.l.
Conclusion:
Understanding the relative contributions of morphologically indistinguishable species to LF transmission is essential if PCR is to be performed on mosquito pools. In the study area, the use of mosquito pools composed of A. gambiae sibling species would not be problematic, as both A. gambiae s.s. and A. arabiensis contribute equally to LF transmission.
Monitoring lymphatic filariasis interventions: Adult mosquito sampling, and improved PCR - based pool screening method for Wuchereria bancrofti infection in Anopheles mosquitoes Daniel BoakyeHelena BaidooEvans GlahCharles BrownMaxwell AppawuMichael Wilson Thu, 29 Nov 2007 00:00:00 -0000
Background:
Monitoring and evaluation are essential to the successful implementation of mass drug administration programmes for LF elimination. Monitoring transmission when it is low requires both large numbers of mosquito vectors and sensitive methods for detecting Wuchereria bancrofti infections in them. PCR-based methods are preferred over classical dissections but the best protocol so far achieved detection of one L3 Wuchereria bancrofti larva in a pool of 35–50 Anopheles mosquitoes. It also lacks consistency and remains still a costly tool. Hence we decided to improve upon this to achieve detection in a pool of 100 or more by enhancing the quality of the template DNA. Prior to this we also evaluated three vector sampling methods in the context of numbers for monitoring.
Methods:
Human landing, pyrethrium spray and light traps catches were conducted concurrently at sites in an LF endemic district in Ghana and the numbers obtained compared. Two DNA extraction methods; Bender buffer and phenol/chloroform purification, and DNAeasy Tissue kit (Quaigen Inc) were used on pools of 25, 50, 75 100 and 150 mosquitoes each seeded with one L3 or its quivalent amount of DNA. Then another set of extracted DNA by the two methods was subjected to Dynal bead purification method (using capture oligonucleotide primers). These were used as template DNA in PCR to amplify W. bancrofti sequences. The best PCR result was then evaluated in the field at five sites by comparing its results (infections per 1000 mosquitoes) with that of dissection of roughly equal samples sizes.
Results:
The largest numbers of mosquitoes were obtained with the human landing catches at all the sites sampled. Although PCR detection of one L3 in pools of 25, 50 and 75 mosquitoes was consistent irrespective of the extraction method, that of one L3 in 100 was only achieved with the kit-extracted DNA/Dynal bead purification method. Infections were found at only two sites by both dissection and pool-screening being 14.3 and 19 versus 13.4 and 20.1 per 1000 Anopheles mosquitoes respectively, which were not statistically significantDiscussion and conclusionHLC still remains the best option for sampling for the large numbers of mosquitoes required for monitoring transmission during MDA programmes, when vector population densities are high and classical indices of transmission are required. One – in – 100 detection is an improvement on previous PCR pool-screening methods, which in our opinion was a result of the introduction of the extra step of parasite DNA capture using Dynal/beads. As pool sizes increase the insects DNA will swamp parasite DNA making the latter less available for an efficient PCR, therefore we propose either additional steps of parasite DNA capture or real-time PCR to improve further the pool screening method. The study also attests also to the applicability of Katholi et al's algorithm developed for determining onchocerciasis prevalence in LF studies.
The geographical distribution of lymphatic filariasis infection in MalawiBagrey NgwiraPhillimon TambalaA Maria PerezCameron BowieDavid Molyneux Thu, 29 Nov 2007 00:00:00 -0000
Mapping distribution of lymphatic filariasis (LF) is a prerequisite for planning national elimination programmes. Results from a nation wide mapping survey for lymphatic filariasis (LF) in Malawi are presented. Thirty-five villages were sampled from 23 districts excluding three districts (Karonga, Chikwawa and Nsanje) that had already been mapped and Likoma, an Island, where access was not possible in the time frame of the survey. Antigenaemia prevalence [based on immunochromatographic card tests (ICT)] ranged from 0% to 35.9%. Villages from the western side of the country and distant from the lake tended to be of lower prevalence. The exception was a village in Mchinji district on the Malawi-Zambia border where a prevalence of 18.2% was found. In contrast villages from lake shore districts [Salima, Mangochi, Balaka and Ntcheu (Bwanje valley)] and Phalombe had prevalences of over 20%.A national map is developed which incorporates data from surveys in Karonga, Chikwawa and Nsanje districts, carried out in 2000. There is a marked decline in prevalence with increasing altitude. Further analysis revealed a strong negative correlation (R2 = 0.7 p < 0.001) between altitude and prevalence. These results suggest that the lake shore, Phalombe plain and the lower Shire valley will be priority areas for the Malawi LF elimination programme. Implications of these findings as regards implementing a national LF elimination programme in Malawi are discussed.
Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri LankaMirani WeerasooriyaChanna YahathugodaDarshana WickramasingheKithsiri GunawardenaRohan DharmadasaKanchana VidanapathiranaSaman WeerasekaraWilfred Samarawickrema Thu, 15 Nov 2007 00:00:00 -0000
Background:
In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg/kg treatment microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC albendazole combination was conducted in 2002.
Methods:
We investigated the extent social mobilisation had reached the people, their drug compliance and adverse reactions. Three localities were selected from each district to pick target population samples for pre-tested questionnaire. Three teams each with six people visited one district each day. One team worked from three starting points in one locality. A member applied eight part questionnaire to one family member totalling 150–160 people from one locality. Questions included social mobilisation, drug compliance and adverse reactions.
Results:
Information was disseminated by television, radio, banners and leaflets, to a lesser extent by people. Information reached more people in the periphery than in Colombo. 35.2% from Colombo municipality were unaware of the MDA. Drug coverage was 79.6%, home delivery 71.7% and delivery centres 7.9%. 35.6% in Colombo district and 53.4% from Colombo municipality did not receive drugs. Drugs were consumed by 71.4%. 28.6% who did not comply included 20.4% who did not receive them. 91.4% showed no adverse reactions, 7.5% were mild, 1.1% recovered with home remedies.
Conclusion:
Drug compliance showed significant positive correlation with awareness of the MDA. Door to door delivery was more successful than delivery from centres. More delivery centres conveniently located would have rectified this disparity. Poor awareness and compliance in Colombo and urban areas could be rectified with separate strategy for urban areas. More time for MDA and trained adequate manpower would ensure coverage to achieve elimination.
Subscribe to Parasitic RSS feed 
Al-Quds University - Leishmaniasis Research - Information about the disease, including its status in Palestine. Includes research topics, links, protocols, publications and photos.
Immunization Against Visceral Leishmaniasis - Simona Stäger, Deborah F. Smith and Paul M. Kaye. Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. Journal of Immunology.
Leishmaniasis (CDC - DPDx) - US government site includes causal agent, life cycle, geographic distribution, clinical features, laboratory diagnosis and features. From the Division of Parasitic Diseases, Center for Disease Control and Prevention.
Leishmaniasis, All About - Introduction, morphology, transmission, immunology, and treatment. From the University of East London, B.Sc Applied Biology course project.
Leishmaniasis, Canine - Immunization using interferon-gamma as an adjuvant.
Leishmaniasis, Canine - From Oklahoma State, Veterinary Parasitology 5333
Meta Description: [ OSU-CVHS is a public, four-year, nationally accredited Veterinary Medicine training program. The CVHS campus focuses on DVM and graduate level education, providing opportunities for individuals to earn DVM, masters and doctorate degress. ]
Leishmaniasis, Cutaneous - Treatment (Israel).
Leishmaniasis, Government (CDC) - Reports: Morbidity and Mortality Weekly Report, Emerging Infectious Diseases. From Centers for Disease Control and Prevention (CDC).
Leishmaniasis, Government (CSR) - Disease situation, disease control activity, more information about the disease, links. From Communicable Disease Surveillance and Response (CSR).
Leishmaniasis, Government (TDR) - Update, project reports, highlights, progress, publications, workplans and research grants, resources. From WHO/TDR (World Health Organization/Tropical Disease Research and Training).
Leishmaniasis, Technical - Slides of L.donovani and L.mexicana. From Atlas of Medical Parasitology (Italy).
Leishmaniasis, Technical - Summary information plus clickable slides, references and world maps. From Christian de Duve Institute of Cellular Pathology.
Leishmaniasis, Technical - Information on Cutaneous, Mucocutaneous, and Visceral types. From University of Texas Medical Branch, Graduate School of Biomedical Sciences, Microbiology, 'Hemoflagellates'.
Leishmaniasis, Travel - Health information for international travel. From Centers for Disease Control and Prevention (CDC).
Meta Description: [ Official U.S. government health recommendations for traveling. Provided by the U.S. Centers for Disease Control and Prevention (CDC). ]
Leishmaniasis, Visceral - From University of East London, B.Sc Microbiology course project.
MedlinePlus: Leishmaniasis - Directory of news, articles, and factsheets.
Meta Description: [ Leishmaniasis ]
Persian Gulf Experience and Health (CBM 94-3) - 594 selected citations from 1971-1994. From National Library of Medicine.
Persian Gulf, The Impact of Infectious Diseases on the Health of U.S. Troops - Includes Leishmaniasis as one of the diseases studied in connection with Operations Desert Shield/Desert Storm. From Office of the Special Assistant for Gulf War Illnesses, reprinted from Clinical Infectious Diseases.
Third Cost-B9 Congress - Leishmaniasis seminar in Bruges, Belgium on 29-31 May 2000 sponsored by COST-B9 (European Cooperation in the field of Scientific and Technical Research).